Issue 94, 2022

A DNA–Au nanomachine activated by dual types of biomarkers for multi-site imaging and gene silencing

Abstract

A programmed DNA–Au nanomachine has been constructed to achieve in situ imaging of transmembrane glycoprotein MUC1 and cytoplasmic miRNA-21 and trigger gene silencing therapy. The results of MCF-7 cell-specific imaging and apoptosis experiments demonstrate that the nanomachine provides a valuable nanotheranostic platform for accurate multi-site imaging and intracellular gene silencing.

Graphical abstract: A DNA–Au nanomachine activated by dual types of biomarkers for multi-site imaging and gene silencing

Supplementary files

Article information

Article type
Communication
Submitted
12 Sep 2022
Accepted
01 Nov 2022
First published
01 Nov 2022

Chem. Commun., 2022,58, 13107-13110

A DNA–Au nanomachine activated by dual types of biomarkers for multi-site imaging and gene silencing

Y. Zhou, Z. Li, T. Wu, J. Ning, G. Hu and Y. Nie, Chem. Commun., 2022, 58, 13107 DOI: 10.1039/D2CC05017J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements